Role of platinum-based radio-chemotherapy for locally advanced non-small-cell lung cancer: Possible influence of type of platinum on survival data [6]

Annals of Oncology

Volumn 17, Issue 11, 2006, Pages 1724-

  Hotta, K ^a   Kiura, K ^a  

^a OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; PLATINUM COMPLEX;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; META ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

EID: 33750598151     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl130     Document Type: Letter

References (3)

1. Auperin A, Le Pechoux C, Pignon JP et al. Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small-cell lung cancer (NSCLC): A meta-analysis of individual data from 1764 patients. Ann Oncol 2006; 17: 473-483.
2. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small-cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 1995; 311: 899-909.
3. Burdett S, Stewart L, Pignon JP. Chemotherapy in non-small-cell lung cancer: An update of an individual patient data meta-analysis. J Clin Oncol 2005; 23: 924-925.